Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein

EU orphan designation number: EU/3/12/1039   
Active ingredient: Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein
Indication: Treatment of cutaneous T-cell lymphoma
Sponsor: AOP Orphan Pharmaceuticals AG
Wilhelminenstraße 91/IIf/B4, A-1160 Wien, Österreich

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/08/2012 Centralised Orphan - Designation EMA/OD/066/12 (2012)5802 of 09/08/2012